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VEGFLbh is thought to act as a transcriptional cofactor and is highly conserved among species. Here we show that
Lbh is expressed in chondrocytes, cells of the perichondrium, and the primary spongiosa in fetal growth
plates of mice and chickens. Lbh overexpression in chick wings, using the RCAS-retroviral vector strategy,
results in shortened skeletal elements and delayed hypertrophic chondrocyte maturation and bone
formation. Additionally, osteoclast and endothelial cell invasion are delayed in the Lbh-overexpressing bones.
Finally, we ﬁnd a dramatic suppression of Runx2 and VEGF mRNAs in chondrocytes and osteoblasts that
overexpress Lbh. Strikingly, this abnormal bone development in infected limbs can be rescued by concurrent
overexpression of Runx2. These results suggest that during endochondral bone formation, Lbh may
negatively regulate vascular invasion and formation of the early ossiﬁcation center at least in part by
interfering with Runx2 and/or VEGF expression.
© 2009 Elsevier Inc. All rights reserved.Introduction
In endochondral bone development mesenchymal condensates
differentiate into chondrocytes that proliferate to form and enlarge
the bone structure (Erlebacher et al., 1995; Karsenty, 2001; Kronen-
berg, 2003). Over time, cells in the center stop proliferating, become
hypertrophic (named hypertrophic chondrocytes) and generate the
surrounding matrix. They express predominantly type X collagen (col
X), attract blood vessels and induce adjacent perichondrial cells to
become osteoblasts, leading to the formation of a bone collar. With
vascular invasion, osteoblasts appear in the primary spongiosa (PS)
and there begin to synthesize new bone. Chondrocytes continue to
proliferate and undergo well-ordered phases of maturation. This
region of chondrocyte proliferation and maturation adjacent to the PS
is often called the fetal growth plate. In long bones of the limbs,
growth plates are detectable around embryonic day (E)14.5 in mice
and around Hamburger–Hamilton (HH) stage 36 (E10) in chickens.
The chondrocytes undergo cycles of proliferation, ﬂatten and form
orderly columns, become hypertrophic and eventually die, to be
replaced by osteoblasts adjacent to the growth plate in the marrow
space and the bone collar. While undergoing the different maturation
stages, chondrocytes respond to a variety of signals to activate speciﬁc
transcription factors (TF) that direct this maturation.(H.M. Kronenberg).
l rights reserved.One crucial and well-characterized TF in the process of differentia-
tion of both chondrocytes and osteoblasts is Runx2, which is mainly
expressed in prehypertrophic and hypertrophic chondrocytes, as well
as in perichondrial cells and osteoblasts (Karsenty, 2001; Komori,
2003). Loss of Runx2 in genetically engineered mice severely delays
chondrocyte maturation and suppresses osteoblast development
(Inada et al., 1999; Kim et al., 1999; Komori et al., 1997; Otto et al.,
1997). Conversely, transgenic expression of Runx2 speciﬁcally in
chondrocytes accelerates chondrocyte hypertrophy. Additionally,
Runx2 is a necessary component of a tissue-speciﬁc genetic program
that regulates production of vascular endothelial growth factor
(VEGFA, here called VEGF) (Zelzer et al., 2004). Runx2-deﬁcient
mice present an almost complete lack of VEGF expression in
hypertrophic chondrocytes as well as a dramatic decrease in levels
of the VEGF receptors in perichondrial cells (Zelzer et al., 2001). Partial
loss of VEGF proteins inmice impairs skeletal angiogenesis, and delays
chondrocyte hypertrophy, bone formation and cartilage calciﬁcation
(Maes et al., 2002; Zelzer et al., 2002).
To identify novel regulators of chondrocyte differentiation, we
analyzed the genes expressed in discrete layers (round, ﬂat and
hypertrophic cell layers) of newborn (NB) wild-type (WT) mice
growth plates by microarray analysis (Nishimori et al., manuscript in
preparation), focusing on genes differentially expressed across the
growth plate. We found that the transcriptional cofactor limb-bud-
and-heart (Lbh) is weakly expressed in round and ﬂat chondrocytes,
but strongly expressed in late hypertrophic chondrocytes and
osteoblasts. Lbh was discovered as a small acidic nuclear protein
highly conserved among species (Xenopus, Mammals, Avians,
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Lbh was given to the protein because of its prominent expression in
fetal life in the early limb bud and heart. Lbh has no known DNA-
binding domain, though it can activate expression of a reporter gene
when fused to the DNA-binding domain of GAL4 (Briegel and Joyner,
2001). In humans the Lbh gene is located on chromosome 2p. In mice,
the transgenic expression of Lbh in the heart from the three somite
stage onwards leads to a broad spectrum of cardiovascular defects
mimicking the partial trisomy 2p syndrome described in humans
(Briegel et al., 2005). In endochondral bone formation, the role of Lbh
is completely unknown. In case reports of human fetuses with partial
trisomy 2p syndrome, skeletal phenotypes such as polydactyly and
scoliosis have been described (Hahm et al., 1999). Since Lbh in fetal/
newborn bones in mice is mainly expressed in late hypertrophic
chondrocytes and osteoblasts, we hypothesized that Lbh might play a
role in hypertrophic chondrocyte maturation and/or formation of the
primary ossiﬁcation center (POC).
Here, we demonstrate the expression of Lbh transcripts in
developing chondrocytes, cells of the perichondrium and of the
POC in both mice and chicken fetal growth plates. Forced expression
of Lbh in developing chicken wings impairs chondrocyte hypertro-
phy, growth plate vascularization, bone formation and osteoclast
invasion. Furthermore, forced expression of Lbh leads to a dramatic
decrease of Runx2 and VEGF mRNA expression in multiple cell types
in developing limbs. Comparable effects were observed after forced
Lbh expression in chick primary chondrocytes and in murine
chondrogenic and osteogenic cell lines. Double-overexpression of
Lbh and Runx2 in avian in vivo and in vitro models rescues the Lbh-
induced phenotype. These ﬁndings suggest a possible role of Lbh in
the tight regulation of Runx2 transcription as well as a possible role
of Lbh in the regulation of VEGF mRNA expression during
endochondral bone development. Thus Lbh has previously unrecog-
nized crucial roles in chondrocyte hypertrophy, vascular invasion
and osteoblast maturation.
Materials and methods
Generation of RCAS-Lbh retroviruses and retroviral overexpression
RCASBP(A)-Lbh and RCASBP(B)-Lbh were generated by RT-PCR
(for cloning details see supplementary data). Infective viruses were
generated as described elsewhere (Logan and Tabin, 1998). RCAS
viruses were micro-injected into chicken limb buds at embryonic
stage HH18–20 (E3–E3.5) in ovo and the embryos were further
incubated until the designated stage between HH33 and HH42 (E7.5–
E13). In each experiment the infected wing was compared to the
uninfected wing of the same animal that served as the “WT”-control.
For our rescue experiments we took advantage of the possibility to co-
overexpress two different genes in the same cells using two RCAS
viruses of different subgroups A and B.
In situ hybridization (ISH)
Details of the probes employed for ISH are available upon request.
Parafﬁn sections of embryonic chick and mouse tissue were prepared
as described (Murtaugh et al., 1999). Non-radioactive ISH, with
digoxigenin (DIG)-labeled probes (Murtaugh et al., 2001) as well as
ISH with 35S-labeled riboprobes was performed as described pre-
viously (Chung et al., 1998). Autoradiography, Hoechst 33258 staining
(Invitrogen) as well as photography have been performed as
described elsewhere (Sundin et al., 1990).
Tissue culture experiments
Chicken upper sternal chondrocytes were harvested and cultured
as described (Grimsrud et al., 1999; Usui et al., 2008). The primarily
isolated cells were plated in 100 mm tissue culture dishes at a density
of 3×106 cells and cultured for 5 days when the chondrocytes were inthe supernatant. Then the chondrocytes were harvested and retroviral
infection was performed with an empty RCAS virus (RCAS-EV), RCAS-
GFP, RCAS-Lbh and RCAS-Runx2 before starting the secondary cultures
in 12-well plates at a density of 11×105 cells. The cells were cultured
for 48 h to 7 days for gene expression experiments.
Mouse chondroblastic cells of the ATDC5 cell line and mouse
osteoblastic cells of the MC3T3 cell line were used. ATDC5 cells were
cultured in a 1:1 mixture of DMEM and Ham's F-12 medium (DMEM/
F-12; Invitrogen) containing 5% FBS (Invitrogen), 50 U/ml penicillin
and 50 μg/ml streptomycin (Invitrogen). For induction of differentia-
tion, media were supplemented with 10 μg/ml human transferrin,
3×10−8 M sodium selenite and 10 μg/ml bovine insulin (ITS)
(Roche). MC3T3 cells were cultured in αMEM (Invitrogen) containing
5% FBS (Invitrogen), 50 U/ml penicillin and 50 μg/ml streptomycin
(Invitrogen). For induction of mineralization, media were supplemen-
ted with β-glycerol phosphate (10 mM) and ascorbic acid (50 μg/ml)
(Sigma).
For stable transfections, ATDC5 cells and MC3T3 cells were plated
at a density of 2×105 cells/cm2. After 24 h, they were stably
transfected with pcDNA3.1 containing the full-length coding region
of Lbh (generously provided to us by Dr. Karoline Briegel, University of
Miami) (Lbh) (Briegel et al., 2005) or with the empty vector (EV,
Invitrogen) using the Effectene transfection reagent (QIAGEN)
according to the manufacturer's instructions. After 24 h, and every
48 h thereafter for 2 weeks, media were replaced with fresh media
containing 300 μg/ml of G418. This dose and duration of treatment
resulted in the death of all nontransfected cells within 10 days. Pools
of 12 clones of Lbh and EV were isolated for further studies.
Quantitative reverse transcriptase-PCR
Total RNA was extracted from isolated and crushed carpometa-
carpals and ulnae of HH39 old control and RCAS-Lbh overexpressing
chicken wings by using the RNeasy Micro Kit (QIAGEN) according to
the manufacturer's instructions. cDNA synthesis was performed by
using random hexamers with the Protoscript First Strand cDNA
Synthesis Kit (New England Biolabs), and quantitative PCR was
performed by using DNA Engine Opticon 2 Continuous Fluorescence
Detection System (Biolab, Boston, MA) and the Sybr green mix
(Applied Biosystems, Lincoln, CA). Signals were normalized to either
chicken GAPDH (Dong et al., 2006) or mouse β-actin (Bastepe et al.,
2004). Each reactionwas performed in quadruplicate and repeated on
different sample sets to conﬁrm the results. For primer details, see
supplementary data.
Statistical analyses
Data are expressed as mean±SEM. Statistical signiﬁcance was
assessed by Student's T test. Values were considered statistically
signiﬁcant when pb0.05.
Results
Lbh expression in skeletal development suggests a role in cartilage and
bone formation
While analyzing the expression of TF in the discrete layers of the
mouse newborn growth plate using microarray analysis and quanti-
tative real-time reverse transcriptase polymerase chain reaction (QRT-
PCR), we found that Lbh was expressed in round, ﬂat but predomi-
nantly hypertrophic chondrocytes (data not shown). To further
characterize Lbh expression we performed in situ hybridization
(ISH) analysis. In E14.5 mouse embryos Lbh mRNA was highly
expressed in round chondrocytes (Fig. 1A). In newborn (NB) mice
we found Lbh mRNA expressed in round, ﬂat and late hypertrophic
chondrocytes, as well as cells of the perichondrium and the POC (Fig.
1B and S4). We also analyzed Lbh expression in chicken wings at
comparable stages of development. Altogether, the Lbh mRNA
Fig. 1. Lbh expression in the fetal growth plate of mouse and chicken. (A) In WT mouse
growth plates at E14.5 Lbh are highly expressed in round and ﬂat proliferating
chondrocytes while there is no Lbh expression in early hypertrophic chondrocytes
(compared to collagen X mRNA (ColX; Col10a) expression). Lbh is also expressed in
cells of the perichondrium and in the surrounding soft tissues. (B) ISH for Lbh inWT NB
mice, showing that Lbh is expressed in round, ﬂat and late hypertrophic chondrocytes,
cells of the POC, the perichondrium and in the bone surrounding tissues. (Black arrows
indicate identical positions near lower end of region of collagen X mRNA expression on
serial sections of the same bone.) (C) ISH for Lbh in WT chickens at stage HH39 (E11).
Lbh is expressed in round (white arrows, compare to col II mRNA expression on a serial
section of the same bone), ﬂat, and late hypertrophic chondrocytes (black arrows,
compare to OP mRNA expression on a serial section of the same bone), cells of the POC,
the perichondrium and in the tissues surrounding bone.
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ment. In chickenwings at HH39 (roughly equivalent to E11 in the limb
growth plate), a developmental time when the fetal growth plate is
formed and the POC appears, we found LbhmRNA expressed in round,
ﬂat, and late hypertrophic chondrocytes, as well as in the perichon-
drium and POC (Fig. 1C). In the chick the late hypertrophic layer is
more prominent than in the mouse, making the expression in this
layer particularly clear. High levels of Lbh transcripts were also found
in surrounding limb tissue in both mice and chickens.Lbh overexpression during chicken wing development impairs
hypertrophic chondrocyte maturation, vascular invasion, and bone
formation
The distribution of Lbh mRNA expression in the fetal growth plate
of the developing endochondral bone suggests a potential role for Lbh
in the control of chondrocyte proliferation and maturation, and bone
formation. To further investigate this hypothesis we infected chicken
wing buds with the Replication-Competent ASLV long terminal repeat
with Splice acceptor (RCAS) retroviral vector type (A) encoding
chicken Lbh to demonstrate its actions during cartilage and bone
formation and growth. The RCAS vector type (B) encoding chicken Lbh
was also used. Both Lbh-encoding vectors showed comparable results.
Infections were performed at HH18–20 (E3–3.5) and the embryos
were allowed to develop through HH33 and HH42 (E7.5–E13),
stages at which hypertrophic chondrocytes and the bone collar are
normally seen. Skeletal preparation of RCAS-Lbh overexpressing
wings of E11 (HH39) chicken embryos revealed that the long bones
were normally shaped; however, both the overall lengths of the
bones and the zones of mineralization (marked by Alizarin Red
staining) were shorter when infected wings were compared to the
control wings (Fig. 2A). The difference in the lengths of humerus,
ulna and carpometacarpal between control and infected limbs is
particularly statistically signiﬁcant. This suggests a delay in endo-
chondral ossiﬁcation (Fig. 2A).
Histological analysis demonstrated that in HH33 (E7.5) uninfected
contralateral control carpometacarpal bone, hypertrophic chondro-
cytes are present in the center of the developing cartilage but not in
RCAS-Lbh overexpressing bones (Figs. 2Ba and b, Bc and d).
In chicken carpometacarpals vascular invasion normally starts
around HH37 (E10.5) (Fig. 2Bc), followed by vascular ingrowth,
cartilage resorption and the beginning of the formation of the POC
(Fig. 2Bg). Again, this whole process was delayed in the RCAS-Lbh
overexpressing wings at comparable stages (Fig. 2Bd, f, h). This
phenotype was observed in 98% of RCAS-Lbh-infected wings (nN90)
with mild variations in the phenotypic expression, perhaps due to
variation of the infection efﬁciency or variable age at the time of
infection. Control experiments using an RCAS-GFP virus revealed a
comparable and normal development of both control and infected
wings, thereby excluding a viral nonspeciﬁc and/or manipulation-
induced effect (Fig. S1A). The overexpression efﬁciency was tested by
ISH analyses for Lbh mRNA expression (Fig. S1B) as well as QRT-PCR
analysis (Fig. 6A). Over time, development of the RCAS-Lbh over-
expressing wings caught up with that of control wings after a delay of
1–2 days (Fig. 2C).
The delayed hypertrophic chondrocyte maturation, vascular
invasion and bone formation led us to assess whether the
regulation of chondrocyte and/or osteoblast development were
disturbed. Therefore, we investigated the expression of stage-
speciﬁc differentiation markers of these cell types using ISH.
Strikingly, at stage HH33, at which hypertrophic chondrocytes are
visible in the carpometacarpals of control but not RCAS-Lbh
overexpressing wings, there was also no detectable expression of
the hypertrophic chondrocyte marker collagen X mRNA (col X) in
RCAS-Lbh infected wings. In contrast, both control and RCAS-Lbh
overexpressing wings revealed normal expression of the proliferat-
ing chondrocyte marker, collagen II mRNA (col II) (Fig. 3Aa–d). ISH
analyses of later stages also showed a normal distribution of
transcripts for proliferating chondrocytes marked by col II and for
prehypertrophic chondrocytes marked by Indian hedgehog (Ihh)
(Fig. 3Ae–h). Somewhat surprisingly, given the normal distribution
of proliferative chondrocyte markers, BrdU labeling of RCAS-Lbh
infected wings revealed a higher proliferation rate of periarticular
cells and a higher cell number in RCAS-Lbh overexpressing chicken
wings (Fig. S2). Comparisons of proliferation rates at varying time
points show that this increase in proliferation is not caused by a
Fig. 2. RCAS-Lbh overexpression delays chondrocyte hypertrophy, vascular invasion and the formation of the POC. (A) Skeletal preparations stained with Alcian Blue and Alizarin Red
at HH39 show a shortened RCAS-Lbh infected wing. Additionally, the zone of mineralization appears shorter and occurs in the ﬁrst digit of the control wing while it is still missing in
the Lbh overexpressing ﬁrst digit (arrowheads). Quantiﬁcation of the humerus, ulna and carpometacarpal length demonstrates a signiﬁcant reduction of the infected bones. Values
are expressed as means±SEM. ⁎pb0.01. (B) (a and b) H&E staining at stage HH33 (ulnae, u) shows a delay in hypertrophic chondrocytes of infected wings (white arrowhead points
to hypertrophic chondrocytes). (c–h) H&E staining between HH37 and HH39 (carpometacarpal, CMC) shows a delay of vascular invasion and bone formation of infected wings. (C)
(a–d) H&E staining between HH39 and HH40 shows a delay of vascular invasion and bone formation of infected wings. (e and f) This phenotype catches up over time (HH42).
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Lbh-infected wings.
Consistent with the eventual appearance of hypertrophic chon-
drocytes in the RCAS-Lbh overexpressing wings over time, by stage
HH36, col X is expressed in a pattern similar to that of the control wing
(Fig. 3Ai and j). Interestingly, however, expression of the late
hypertrophic marker osteopontin (OP) is dramatically reduced and
restricted to a smaller domain in the RCAS-Lbh overexpressing bone
than in the control wing. These data demonstrate that overexpression
of Lbh in chicken wings delays both early and late hypertrophic
chondrocyte maturation.
We next looked at osteoblast maturation and studied markers of
early and mature osteoblasts via ISH analyses. Expression of collagen I
mRNA (col I), a marker of both early and mature osteoblasts, was
found in both control and RCAS-Lbh overexpressing bones, but the
domain of expression was less extensive and the intensity of
expression were much less in the infected bones (Fig. 3Ak and l).
Lbh overexpression also downregulated OP mRNA expression in the
bone collar a molecule produced by more mature osteoblasts (Fig.
3Am and n). These ﬁndings were conﬁrmed by QRT-PCR analysis of
expression of various genes associated with late hypertrophic
chondrocyte and osteoblast development, using isolated and crushed
carpometacarpals and ulnae of HH39 old control and RCAS-Lbh
overexpressing chicken wings: OP, osteocalcin (OC) and MMP13
(synthesized by both late hypertrophic chondrocytes and osteoblasts)
mRNA levels were signiﬁcantly reduced in RCAS-Lbh overexpressing
bones. Furthermore, the level of col I mRNA was reduced, though thedifference was not statistically signiﬁcant. Taken together, these data
suggest that overexpressing Lbh in chicken wings leads to a delay in
hypertrophic chondrocyte development, as well as a delay in
osteoblast development.
Bone collar formation, cartilage resorption, as well as osteoclast and
endothelial cell invasion are delayed in RCAS-Lbh overexpressing chicken
wings
To further investigate the phenotype observed in Lbh-overexpres-
sing wings, we analyzed the bone mineralization of control and RCAS-
Lbh overexpressing carpometacarpals and ulnae at different time
points. In normal endochondral bone development, mineralization of
bone starts in the perichondrial region. This occurs around stage HH34
(E7) in chick ulnae. At this stage, we observed a mineralized bone
collar surrounding the midshaft cartilage (Fig. 4Aa) in the control
bone. Strikingly, this primarily mineralization process could not be
detected in the RCAS-Lbh overexpressing ulna (Fig. 4Ab). Over time,
we observed delayed bone collar formation in the RCAS-Lbh over-
expressing wing. At stage HH39 of control and RCAS-Lbh over-
expressing carpometacarpals, we still saw an underdeveloped bone
collar in the infected bone, as reﬂected by its decreased length and
thickness (Fig. 4Ac and d).We conclude that RCAS-Lbh overexpression
resulted in a delay of bone collar formation preceding the initial
capillary invasion.
Vascular invasion is associated with cartilage resorption in the core
of the endochondral developing bone. At the border between the
Fig. 3.Molecular analysis of RCAS-Lbh overexpressing bones. (A) (a–d) ISH analyses for col II and col X mRNA at HH33. The pattern of col II transcripts is similar in both control and
RCAS-Lbh overexpressing bones whereas col X expression is delayed in RCAS-Lbh overexpressing bones. (c′ and d′) Higher magniﬁcations of c and d. (e–h) ISH analyses for genes
expressed in proliferating chondrocytes ((e, f) col II mRNA) and prehypertrophic chondrocytes, ((g, h) Ihh mRNA) at HH36 revealed a comparable mRNA expression pattern in both
control and RCAS-Lbh overexpressing CMC. (i and j) ISH for col X at HH36 CMC shows a similar expression pattern in control and Lbh-overexpressing bones, reﬂecting a catch up of
the phenotype seen earlier. (k and l) ISH for col I mRNA expression at HH36 shows col I expression in control CMC in the perichondrial region of the developing bones, while Lbh-
overexpressing CMC shows weak expression in the perichondrial area. (m and n) ISH for OP mRNA appeared with aweaker and shorter expression area in Lbh-overexpressing bones
compared to the control bones. (B) QRT-PCR analyses of genes related to osteoblast and late hypertrophic chondrocyte differentiation in HH39 old control (gray bars) and RCAS-Lbh
(white bars) overexpressing wings (n=10). Expression of OC, OP, col I and MMP13 mRNA is decreased in RCAS-Lbh overexpressing bones as compared to the control. Values are
expressed as means±SEM and represent the relative mRNA expression level normalized to GAPDH expression level. ⁎pb0.01.
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delay in mineralization and vascular invasion in RCAS-Lbh over-
expressing bones, we investigated whether cellular apoptosis might
also be affected. In control bones apoptotic cells detected by TUNEL
assay were found in the terminal row of chondrocytes adjacent to the
invading blood vessel as well as in the POC. At comparable stages in
the RCAS-Lbh overexpressing bones, apoptotic cells appear later
(Fig. 4B), consistent with the delay of vascular invasion in RCAS-Lbh
overexpressing bones.
Next we analyzed the cellular correlates of the impaired cartilage
resorption by assessing markers of osteoclast and endothelial cell
invasion. At the stage of vascular invasion in the control bones,
multinucleated TRAP-positive osteoclasts as well as CD31 positive
endothelial cells appeared in the centers of the bones' midshafts,
where blood vessel invasion occurred (Figs. 4C, D). In contrast, in
RCAS-Lbh overexpressing bones, multinucleated TRAP-positive osteo-
clasts were located along the diaphysis, where they appeared to be
lined up at the surface of the bone but were not yet penetrating into
the midshaft center (Fig. 4C). Furthermore, there were fewer CD31
positive endothelial cells, and they were found similarly lined up
along the diaphysis (Fig. 4D). Consistent with the delay in the
resorption process, levels of mRNA encoding MMP9, a key regulator of
growth plate angiogenesis and hypertrophic chondrocyte apoptosis
expressed in osteoclasts and endothelial cells (Vu et al., 1998), were 2-fold reduced in RCAS-Lbh overexpressing bones at HH39 (E11) (Fig.
5E). Taken together, these ﬁndings indicate that RCAS-Lbh over-
expressing chicken wings exhibited a delay in osteoclast and
endothelial cell invasion.
Lbh represses Runx2 and VEGF mRNA expression
We wondered whether Lbh overexpression inhibits chondrocyte
hypertrophy by interfering with the expression of Runx2, a necessary
regulator of chondrocyte hypertrophy. Further, Runx2 also regulates
the expression of vascular endothelial growth factor (VEGF) in
hypertrophic chondrocytes (Zelzer et al., 2004); this VEGF has been
shown to play a crucial role in regulating the formation of the POC
(Carlevaro et al., 2000; Deckers et al., 2000; Engsig et al., 2000; Gerber
et al., 1999). Decreased VEGF expression leads to a phenotype that
resembles the phenotype seen in our overexpression studies (Gerber
et al., 1999; Maes et al., 2002; Zelzer et al., 2002).
We therefore examined the expression of Runx2 and VEGF mRNA
via ISH analysis at stages HH34–39 (E9–11). We found that over-
expressing Lbh dramatically suppresses levels of Runx2 and VEGF
mRNAs in chondrocytes and osteoblasts in comparison to levels in the
control bones (Figs. 5A and S5). The mRNAs were suppressed in both
the bone and in the adjacent soft tissues; the extent of suppression
could not be explained simply by stage-appropriate changes in Runx2
353K.L. Conen et al. / Developmental Biology 333 (2009) 348–358expression (compare expression of Runx2 in Figs. 5A and S5). This was
conﬁrmed in QRT-PCR analysis of control and Lbh-overexpressing
bones at stage HH39 (Fig. 5B). These data suggest that Runx2 and/or
VEGF downregulation might be responsible for the Lbh-induced
phenotype. To test this hypothesis, we asked whether overexpression
of Runx2 could rescue the Lbh-induced delay in hypertrophic
chondrocyte maturation, vascular invasion and bone formation. We
co-infected HH18–20 limb bud with either the viruses RCAS(B)-Lbh
and RCAS(A)-Runx2 (n=12), or the viruses RCAS(A)-Lbh and RCAS(B)-Runx2 (n=5). Chicken embryos were allowed to develop until
HH39 (E11). Together, both injection strategies resulted in reversal of
the abnormal phenotype in 92% (15 versus 17) of the bones studied.
We injected viruses at stage HH18–20 (E3–3.5) and the embryos were
allowed to develop through HH39 (E11). As expected, in control
experiments (Fig. 5C), we observed delay in late hypertrophic
chondrocyte maturation, vascular invasion and formation of the POC
when RCAS(A)-Lbh virus was co-infected along with a control RCAS
(B)-GFP virus. The infection efﬁciency of both Runx2 and Lbh was
tested by ISH (Fig. S3A). Single RCAS-Runx2 overexpression studies
(n=6) showed moderately but consistently advanced vascular
invasion, mineralization and formation of the POC (Fig. S3B). Wings
co-infectedwith RCAS-Lbh and RCAS-GFP showed the phenotype seen
in single RCAS-Lbh overexpressing bones, with a shortened skeletal
element and shortened zone of mineralization, a delayed formation of
the POC and a repressed expression pattern of OP and VEGF mRNA
(Fig. 5Cb, e, h, k, n) at stage HH39 as compared with contralateral
uninfected wings (control) (Fig. 5Ca, d, g, j, m). Strikingly, when
Runx2 was overexpressed along with Lbh, we observed a macro-
scopically and histologically normal looking bone with normal
expression of OP and VEGF (Fig. 5D c, f, i, l, o) in both late hypertrophs
and osteoblasts, demonstrating that Runx2 overexpression rescues
the Lbh-induced phenotype. Thus, retroviral-encoded Lbh inhibits
chondrogenesis and osteogenesis by either directly or indirectly
repressing the expression of both Runx2 and VEGF.
Misexpression of Lbh as well as misexpression of both, Lbh and Runx2 in
avian and murine cell lines in vitro can reproduce parts of the phenotype
seen in vivo
The studies so far involve infection of all cell types in the limb. To
determine whether Lbh overexpression only in chondrocytes mimics
the phenotypes seen in the chondrocytes of Lbh-overexpressing limbs,
we overexpressed Lbh in isolated upper sternal chondrocytes,
chondrocytes that differentiate into hypertrophic chondrocytes in
culture and express hypertrophic chondrocyte speciﬁc markers like
col X. Primary chondrocytes from the upper region from E16 WT
chickens were isolated, infected in vitro with RCAS-Lbh, or RCAS-
empty vector (EV) and cultured for an additional 7–14 days before
harvesting. QRT-PCR analyses demonstrated the following results: Lbh
was expressed at 6-fold higher levels in the RCAS-Lbh overexpressing
cells as compared to the RCAS-EV infected control cells. Strikingly,
there was a dramatic and signiﬁcant downregulation of both Runx-2
and VEGF in the Lbh-overexpressing cells. Additionally, col X and OP
expression were downregulated in the Lbh-overexpressing cells as
compared to the EV-infected cells. We next assessed the effects of
overexpressing both Lbh and Runx2 in primary chondrocytes. QRT-
PCR analyses demonstrated that Runx2 overexpression rescued theFig. 4. Effect of RCAS-Lbh overexpression on bone mineralization, cartilage resorption
and osteoclast and endothelial cell invasion. (A) (a and b) Von Kossa (v.K.) staining of
the CMC at HH36 as well as HH39 (c and d) illustrating impaired bone collar
mineralization in RCAS-Lbh overexpressing bones compared to control bones. (B)
TUNEL staining of CMC of HH36 and HH39 old animals. H&E stained serial sections are
included to identify the regions of cellular apoptosis. While control CMC show apoptotic
cells in the region of vascular invasion, invasion itself as well as apoptosis is delayed in
the RCAS-Lbh overexpressing CMC. (C) TRAP stained CMC at HH39 reveal TRAP-positive
cells in the centers of the midshafts in control bones, whereas in the RCAS-Lbh
overexpressing bones, the TRAP-positive cells occur in the region of the perichondrium.
(D) IHC for CD31 at HH39 CMC. Like in the TRAP staining, brown CD31 staining is more
intense and occurs in the center of the bones' midshafts where vascular invasion occurs
in the control CMC. The Lbh-overexpressing bone shows some single CD31-stained
brown cells in the perichondrial region. (E) QRT-PCR analyses of theMMP9 gene related
to cartilage resorption and osteoclast invasion in HH39 old control (gray bars) and
RCAS-Lbh (white bars) overexpressing wings (n=10). Expression of MMP9 mRNA is
decreased in RCAS-Lbh overexpressing bones as compared to control bones. Values are
expressed as means±SEM and represent the relative mRNA expression level
determined as the ratio of the respective signal to the signal obtained for the chicken
GAPDH gene. ⁎pb0.02.
Fig. 5. RCAS-Lbh overexpression represses Runx2 and VEGF mRNAwhich can be rescued by co-overexpressing Lbh and Runx2 (A) ISH at HH36 (CMC) shows a dramatic repression of
Runx2 and VEGF transcripts. (B) QRT-PCR analyses of Runx2 and VEGF mRNA expression in stage HH39 old control (gray bars) and RCAS-Lbh (white bars) overexpressing wings
(n=10). Expression of both Runx2 and VEGF mRNA is decreased in RCAS-Lbh overexpressing bones as compared to control bones. Values are expressed as means±SEM and
represent the relative mRNA expression level determined as the ratio of the respective signal to the signal obtained for the chicken GAPDH gene. ⁎pb0.02, ⁎⁎pb0.05. (C) Co-
overexpression of RCAS(A)-Lbh (Lbh) and RCAS(B)-Runx2 (Runx2) or Lbh and RCAS-(B)-GFP (GFP) were performed at stage HH20 and reincubated until HH39. Serial sections from
CMC are shown. (a–c) In Lbh-Runx2 double infectedwings skeletal preparations showa rescue of the shortened skeletal elements seen in the Lbh-GFP infectedwing in comparison to
the control wing. (d–i) In Lbh-Runx2 double infected wings H&E and von Kossa staining shows a rescue of the delayed vascular invasion and bone collar formation seen in the Lbh-
GFP infected wing in comparison to the control wing. (j–o) In Lbh-Runx2 double infected wings, in ISH for OP and VEGF show a rescue of the dramatic downregulation of both
markers in the Lbh-GFP infected versus the control wing.
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overexpressing cells (Fig. 6B). We conclude that Lbh overexpression
directly in chondrocytes in vitro mimics the effects of Lbh over-
expression in limbs in vivo on hypertrophic chondrocyte maturation.Fig. 6. Forced Lbh expression in vitro in avian (A and B) and murine (C–F) cell lines. (A) Lbh
Runx2, VEGF, OP and col X. Upper sternal chondrocyteswere infectedwith RCAS(B)-Lbh retro
expression was assayed by QRT-PCR. Values are expressed as means±SEM and represent th
signal obtained for the chicken GAPDH gene. ⁎pb0.01, ⁎⁎pb0.001. (B) Lbh and Runx2 co-ove
VEGF mRNA. Upper sternal chondrocytes were infected with RCAS(B)-EV (gray bar), RCAS(B
for 7 days. Gene expressionwas assayed by QRT-PCR. Values are expressed asmeans±SEM an
signal to the signal obtained for the chicken GAPDH gene. ⁎pb0.02, ⁎⁎pb0.01. (C) Forced Lbh
mineralization nodules. ATDC5 cells were stably transfected with pcDNA3.1 empty vector (EV
of d. (e and f) Alizarin Red staining at 30 days. (D) Forced Lbh expression inMC3T3 cells delay
cells were stably transfected with pcDNA3.1 empty vector (EV) or pcDNA3.1-Lbh vector (Lb
staining at 14 days. (g and h) Alizarin Red staining at 30 days. (E) Lbh missexpression in ATD
with pcDNA3.1 EV (gray bar) or pcDNA3.1 Lbh (white bar) and cultured for 7 days. Gene expr
relative mRNA expression level determined as the ratio of the respective signal to the signa
MC3T3 cells decreases mRNA levels of Runx2 and VEGF. MC3T3 cells were stably transfected
expression was assayed by QRT-PCR. Values are expressed as means±SEM. ⁎pb0.01.It is most likely that Lbh regulates this process via the regulation of
Runx2 and VEGFmRNA expression, as a double-infectionwith Lbh and
Runx2 could rescue the Lbh-induced decreased differentiation and
downregulation of VEGF mRNA expression.overexpression in primary cultures of chicken chondrocytes decreases mRNA levels of
virus (white bar) or RCAS(B)-empty vector (EV) (gray bar) and cultured for 7 days. Gene
e relative mRNA expression level determined as the ratio of the respective signal to the
rexpression in upper sternal chondrocytes can rescue the decreased levels of Runx2 and
)-Lbh (white bar) or RCAS(B)-Lbh/RCAS(A)-Runx2 (black bar) retrovirus and cultured
d represent the relativemRNA expression level determined as the ratio of the respective
expression in ATDC5 cells delays alkaline phosphatase (AP) expression and formation of
) or pcDNA3.1-Lbh vector (Lbh). (a–d) AP staining at 14 days. (d′) Phase contrast picture
s alkaline phosphatase (AP) expression and formation of mineralization nodules. MC3T3
h). (a–d) AP staining at 14 days. (d′) Phase contrast picture of d. (e and f) Alizarin Red
C5 cells decreases mRNA levels of Runx2 and VEGF. ATDC5 cells were stably transfected
essionwas assayed by QRT-PCR. Values are expressed as means±SEM and represent the
l obtained for the mouse β-actin gene. ⁎pb0.01, ⁎⁎pb0.004. (F) Lbh missexpression in
with pcDNA3.1 EV (gray bar) or pcDNA3.1 Lbh (white bar) and cultured for 7 days. Gene
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similar to that in chickens, we wondered if Lbh overexpression would
have similar effects in a mouse chondrocyte model. To assess whether
stable expression of Lbh could delay chondrocyte differentiation
murine ATDC5 cells, a chondrocyte line that differentiates into
hypertrophic chondrocytes in vitro, were stably transfected with
pcDNA3.1-Lbh (Lbh) or pcDNA3.1-empty vector (EV). After 14 days in
culture, the stably Lbh-transfected ATDC5 cells failed to show anyalkaline phosphatase (AP) positive staining (a marker of hypertrophic
chondrocytes), while the stably EV-transfected ATDC5 cells showed
positive, blue AP staining of the cells (Fig. 6Ca–d). Of note, cell
conﬂuence did not differ between both cell types (Fig. 6Cd′). Next we
examined the effect of stable expression of Lbh on mineralized matrix
formation, a ﬁnal step in chondrocyte differentiation. Alizarin Red
positive nodules were detected after 30 days in culture only in the EV-
transfected ATDC5 cell, while mineralized nodules were not
356 K.L. Conen et al. / Developmental Biology 333 (2009) 348–358detectable in the Lbh-transfected cells at that time (Fig. 6Ce and f). At
7 days ATDC5-Lbh clones expressed 20.0±0.2-fold higher Lbh mRNA
levels than ATDC5-EV clones. As in avian cells, we observed a
signiﬁcant, approximately 80% downregulation of VEGF mRNA levels
in the Lbh-transfected cells, as well as an approximately 70%
downregulation of Runx2 mRNA levels compared to the EV-trans-
fected cells. Aggrecan mRNA, as a speciﬁc early chondrocyte marker
was expressed without a difference in both Lbh- and EV-transfected
ATDC5 cells (Fig. 6E).
To determine whether the effects of Lbh overexpression in
osteoblasts involve direct actions on osteoblasts, murine MC3T3
cells were used. These cells have characteristics of preosteoblasts
with the capability to become mature osteoblasts in prolonged
cultures at higher cell densities. MC3T3 cells were stably transfected
with pcDNA3.1-Lbh (Lbh) or pcDNA3.1-empty vector (EV). After
14 days in culture, the EV-transfected MC3T3 cells started to express
AP while this expression was still missing in the Lbh-transfected cells
(Fig. 6Da–d). To assess a possible impairment of differentiation as
reﬂected in the ability to form mineralized bone nodules, we cultured
MC3T3-Lbh and MC3T3-EV cells in mineralization medium for
various times. At 14 days, the MC3T3-EV cells started to form
mineralized nodules, while those could not be detected at the same
time in MC3T3-Lbh cells (Fig. 6De and f). The number of nodules was
still strikingly decreased at 30 days in Lbh-transfected cultures
compared to EV-transfected cultures (Fig. 6Dg and h). To determine
whether Runx2 and VEGF expressions were altered by forced
expression of Lbh in MC3T3 cells, cells cultured for 7 days were
harvested and examined by QRT-PCR analyzes. Again, both Runx2 and
VEGF mRNA levels appeared to be dramatically and signiﬁcantly
downregulated in MC3T3-Lbh cells compared to MC3T3-EV cells,
while col I mRNAwas expressed at a similar level in both EV and Lbh-
transfected cells (Fig. 6F). The ﬁndings demonstrate that in both avian
and murine cells, the forced expression of Lbh leads to a delay in
chondrocyte and osteoblast development with a delay of mineraliza-
tion. The in vitro studies suggest that the effects of Lbh over-
expression in chondrocytes and osteoblasts are cell-autonomous
actions of Lbh in each cell type.
Discussion
Recent work by a number of groups has begun to clarify the process
of late hypertrophic chondrocyte maturation, vascular invasion and
bone formation. These processes involve mechanisms linking Runx2
and VEGF regulation (Papachristou et al., 2005; Zelzer et al., 2001). In
this report, we have uncovered a possibly crucial novel regulator of
this process: Lbh. This study indicates that expression of Lbh can
inﬂuence normal angiogenesis, endochondral ossiﬁcation, and bone
formation at least partly through regulation of Runx2 mRNA
expression.
Lbh overexpression in developing chondrocytes and osteoblasts
leads to three defects that we demonstrate: ﬁrst, a delay in initial
hypertrophy; second, delays in late hypertrophy and vascular
invasion; and third, defects in mineralization of bone. The con-
sequences of Lbh overexpressionmight result exclusively from actions
on early hypertrophic chondrocytes, as these cells control all the
subsequent steps in endochondral bone development. Several argu-
ments suggest, however, a series of independent actions of Lbh. First,
the delay in late hypertrophy is associated with dramatic and
prolonged suppression of OP and VEGF mRNA that appear out of
proportion to the hypothesis of simple delay in the generation of late
hypertrophic chondrocytes. Similarly the bone defect is more
pervasive and is accompanied by widespread defects in Runx2
expression in the soft tissues in a way that cannot easily be explained
by poor signalling from hypertrophic chondrocytes. Most importantly
for this argument, the actions of Lbh on isolated MC3T3 osteoblastic
cells sufﬁciently resemble those in the osteoblasts of the infectedchick wings that direct actions of Lbh on both chondrocytes and
osteoblasts seem likely.
Suppression of Runx2 mRNA most likely explains the defects seen
in infected hypertrophic chondrocytes. In chickens andmice, Runx2 as
well as Runx3 are required for chondrocyte hypertrophy (Komori,
2003) and overexpression of Runx2 leads to exaggerated hypertrophy
(Enomoto et al., 2000). The rescue of the Lbh-overexpression
phenotype through overexpression of Runx2, thus, strongly supports
the idea that suppression of Runx2 expression explains the hyper-
trophic chondrocyte phenotype caused by Lbh overexpression.
Further studies will be required to determine whether the Runx2
gene is a direct target of Lbh or instead whether Lbh acts upstream of
the decision to activate Runx2 in chondrocytes.
The defect in osteoblast development, vascular invasion and
mineralization is most likely a consequence of the downregulation of
Runx2 and VEGF mRNA expression in both the chondrocytes and
osteoblasts in the Lbh-overexpressing limbs. Runx2 is required for
osteoblast development in mice (Karsenty, 2001) and also regulates
the expression of VEGF (Zelzer et al., 2001). Thus, the decrease in
VEGF expression seen with Lbh overexpression could reﬂect actions
of Lbh on Runx2 expression and consequent decrease in VEGF
expression or independent actions on the expression of both Runx2
and VEGF.
VEGF is a major regulator of vascular invasion in developing
cartilage (Zelzer et al., 2004) and both VEGF and Runx2 regulate
osteoblast development through actions on osteoblasts (Maes et al.,
2002; Zelzer et al., 2004; Zelzer et al., 2002). Studies of VEGF loss of
function demonstrate an abnormal process of hypertrophic chondro-
cyte maturation, vascular invasion and bone formation (Gerber et al.,
1999; Maes et al., 2002; Zelzer et al., 2002). Those animals, like our
Lbh-overexpressing chicken wings, presented shorter and less miner-
alized bones, as well as decreased expressions of col X, OP, OC, col I,
CD31 and MMP9. Nevertheless, in contrast to what we have reported
here, animals with impaired VEGF protein expression or activity in the
growth plate show an enlargement of the hypertrophic chondrocyte
zone that we did not observe in the Lbh-overexpressing chicken
wings. A possible explanation for this is that decreased Runx2 levels
may balance the increased accumulation of chondrocytes expected
from decreased VEGF expression. Without much Runx2 the slowness
inmaking hypertrophic chondrocytes and the pervasive defects in late
hypertrophy may mean that the generation of late hypertrophic
chondrocytes is not fast enough to lead to major expansion of these
cells in Lbh-overexpressing bones. It is also possible that the loss of
VEGF protein can be mitigated by actions of circulating VEGF.
Together, these data suggest that decreased VEGF levels combined
with decreased Runx2 mRNA levels may explain most of the
consequences of Lbh overexpression in chick wings.
Our studies have focused on roles of Lbh in hypertrophic
chondrocytes and osteoblasts. However, Lbh is also expressed in
proliferating chondrocytes. Perhaps this expression has a role in
stopping expression of Runx2 in these early chondrocytes. Further,
though the proliferative layer of chondrocytes appears relatively
unperturbed in Lbh-expressing limbs, with normal morphology and
expression of col II mRNA, these chondrocytes do exhibit a modest but
deﬁnite increase in proliferation rate, as reﬂected by BrdU incorpora-
tion. Further studies will be needed to deﬁne better the roles of Lbh in
proliferating chondrocytes.
However, given the dramatic reduction in VEGF expression in our
overexpression studies, we would have expected a more dramatic
phenotype with much shorter and misshaped skeletal elements in the
Lbh-infected bones. Nevertheless, our phenotype caught up in 1 to
2 days and the bones never appearedmalformed or misshaped. This is
a very interesting and unexpected observation. Again, one explanation
might be that circulating VEGF might rescue the local lack of VEGF
protein and therefore normalize the developmental status in the Lbh-
overexpressing bone. There are other possible explanations, as well.
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growth plates of the mouse; perhaps Runx3 can also mitigate effects
of Runx2 in the chick (but not the suppression of VEGF expression).
Further, even though the suppression of Runx2 mRNA is visually
dramatic when examined by ISH, the quantitative RT-PCR makes clear
that the suppression of Runx2 mRNA is not complete and would not
be expected to duplicate the precise ﬁndings of the mouse knockout.
Further, we should acknowledge that the actions of the virus may
change over time inways that we did not fullymonitor; this, too, could
explain the paradox of vivid suppression of Runx2 mRNA at the times
checked and the modest net phenotype over time. Finally, it is also
possible that Lbh has other actions besides suppressing Runx2 and
some of those actions may actually lead to a phenotype that is more
normal than the loss of Runx2 would predict.
Lbh is expressed in both mouse and chicken fetal growth plates
with a comparable expression proﬁle: Transcripts appear in prolif-
erative chondrocytes, cells of the perichondrium, late hypertrophic
chondrocytes, and osteoblastic cells of the PS. Moreover, chicken
primary chondrocytes as well as murine chondrocytes and osteoblasts
express Lbh in comparable levels. Because of similar results in both
murine and chicken in vitro cell models, as well as in chick limbs in
vivo, we hypothesize that Lbh, at least in higher vertebrates, might
have evolutionarily conserved functions. The conserved sites of Lbh
expression match well with the sites of action that we observed in the
overexpression studies. As Runx2 is downregulated in infected
chondrocytes and osteoblasts, we speculate that, in the normal
setting, Lbh suppresses expression of Runx2. In proliferative chon-
drocytes, Lbh might be a partner of other regulators that prevent
Runx2 expression in these cells and allow them to proliferate
normally. The decrease in Lbh expression in hypertrophic chondro-
cytes may be required for optimal expression and action of Runx2 in
these cells. In late hypertrophic chondrocytes and osteoblasts, where
Lbh and Runx2 are both expressed, Lbh might be a negative regulator
of Runx2 expression, preventing undesirable consequences of Runx2
overexpession (Enomoto et al., 2000).
The putative role of Lbh as transcriptional cofactor has been
discussed in an Lbh gain of function experiment using transgenic
mice that overexpress Lbh in the heart (Briegel et al., 2005). In those
mice, Lbh may act as a trans-acting modulator of key cardiac
transcription factors, as Lbh overexpression in tissue culture cells
predominantly represses Nkx2.5 and Tbx5, two key-modulators of
cardiac development. It would be pleasing to propose a uniform
mechanism whereby Lbh regulates different key transcription factors
both in heart and bone, but the paucity of biochemical analysis
makes that currently impossible. Further studies, along with much
needed gene ablation experiments will be required to establish the
importance and mechanism of action of this important gene
regulator.
In summary, we have shown that Lbh delays chondrocyte
hypertrophy and negatively regulates late hypertrophic chondrocyte
maturation, bone formation and vascular invasion in the fetal growth
plate. These actions are associated with suppression of Runx2 and
VEGFmRNA and can be reversed by forced expression of Runx2. These
and previous studies (Briegel et al., 2005) suggest that Lbh is an
important regulator of both cardiac and bone development.
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